Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory KRAS G12C Colorectal Cancer This randomized phase Ib ...
- Phase 2 proof of concept trial met primary endpoint of a one-point improvement in PLA score at last visit and safety via local tolerability in 35 patients with seborrheic keratoses (SKs) target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback